Volv Global’s inTrigue machine learning technology detects incidence of disease earlier than currently possible, by analysing vast amounts of medical data to detecting subtle patterns among biomarkers.
This ensures that people on the path to developing diseases can have start their healthcare journey early by receiving early interventions. This improves patient outcomes, reduces healthcare burdens and improves quality of life.
Why early detection matters
Early detection of diseases can significantly alter the course of treatment and improve prognosis. Patients diagnosed early often have better health outcomes, fewer complications, and a higher quality of life. By uncovering patients at the earliest disease stages, we ensure timely medical interventions.
Early treatment, before serious onset of disease, can hinder disease progression and reduce long-term complications for patients.
Clinical trials benefit from a larger patient cohort. Identifying suitable candidates earlier, before conventional treatment, bolsters clinical trial recruitment and leads to more effective trials.
Early diagnosis ensures an optimal patient journey, in which patients receive the right treatments saving years of patient suffering and reducing long-term healthcare costs by prioritising medical resources by need.
Volv Global’s inTrigue powers solutions across stakeholders
Earlier triage of patients into a clinical trial before they are given traditional therapies.
Earlier triage of patients, potentially saving years of incorrect treatment.
Physician support for diagnosis of patients before the development of traditional symptoms.
Find patients before the development of traditional symptoms.
Industry-leading technology at work
inTrigue employs sophisticated AI and machine learning algorithms to sift through vast amounts of medical data, identifying subtle patterns that indicate the early presence of diseases. Our technology surpasses traditional methods, ensuring that no potential patient is overlooked.
Transformative real-world impact
Our technology has already made a significant difference in the lives of many patients by offering early treatment before onset of clinical disease symptoms.
Here are a few examples of how Volv Global and inTrigue have enabled earlier detection and transformed patient care:
Identified early signs in a young patient, allowing for timely intervention and improved health outcomes.
Detected subtle indicators in patient data, leading to early diagnosis and effective treatment plans.
Screened large datasets to find early cases of a rare condition, facilitating early medical intervention and reducing long-term complications.
Shaping the future today
Ready to shape the future of healthcare? Let’s explore how our machine learning solutions can accelerate diagnoses, refine patient journeys, and drive meaningful impact for those who need it most. We value your ideas and expertise, reach out now to unlock new possibilities together.
